SEC Form 4 · accession 0001628280-16-016760
IMMUNIC, INC. · IMUX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Lowell Sears
Director
Period of report
May 24, 2016
Accepted (ET)
May 26, 2016 · 4:49 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001280776
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $8.17 | May 24, 2016 | A | 21,599 | A | — | May 23, 2026 | Common Stock | 21,599 | 21,599 | D |
Explanation of responses
- F1Subject to reporting person's continuing to be a Service Provider (as defined in the 2014 Equity Incentive Plan) through the vesting date, 100% of the shares subject to the option shall vest and become exercisable upon the earlier of the one (1) year anniversary from May 24, 2016 or the day prior to the Company's 2017 annual meeting of stockholders.